Stevanato [STVN] vs Repligen [RGEN] Detailed Stock Comparison
Stevanato
NYSE
Loading...
Repligen
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Stevanato wins in 15 metrics, Repligen wins in 4 metrics, with 0 ties. Stevanato appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Stevanato | Repligen | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 38.58 | 511.11 | Stevanato |
| Price-to-Book Ratio | 4.29 | 3.40 | Repligen |
| Debt-to-Equity Ratio | 29.80 | 33.28 | Stevanato |
| PEG Ratio | 1.03 | 3.19 | Stevanato |
| EV/EBITDA | 25.44 | 55.34 | Stevanato |
| Profit Margin (TTM) | 11.75% | -2.05% | Stevanato |
| Operating Margin (TTM) | 15.03% | 5.28% | Stevanato |
| EBITDA Margin (TTM) | 15.03% | 5.28% | Stevanato |
| Return on Equity | 9.89% | -0.68% | Stevanato |
| Return on Assets (TTM) | 5.20% | 1.13% | Stevanato |
| Free Cash Flow (TTM) | $-184.86M | $142.49M | Repligen |
| 1-Year Return | 0.50% | -19.66% | Stevanato |
| Price-to-Sales Ratio (TTM) | 5.24 | 10.42 | Stevanato |
| Enterprise Value | $7.60B | $7.00B | Stevanato |
| EV/Revenue Ratio | 5.67 | 10.38 | Stevanato |
| Gross Profit Margin (TTM) | 28.06% | 49.98% | Repligen |
| Revenue per Share (TTM) | $4 | $12 | Repligen |
| Earnings per Share (Diluted) | $0.57 | $-0.25 | Stevanato |
| Beta (Stock Volatility) | 0.55 | 1.05 | Stevanato |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Stevanato vs Repligen Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Stevanato | -2.79% | -2.66% | -17.05% | -3.72% | 5.37% | -1.74% |
| Repligen | -2.83% | -2.27% | -0.39% | -1.04% | -24.90% | -15.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Stevanato | 0.50% | 33.84% | 11.79% | 11.79% | 11.79% | 11.79% |
| Repligen | -19.66% | -42.35% | -16.60% | 266.34% | 3,508.93% | 3,025.26% |
Performance & Financial Health Analysis: Stevanato vs Repligen
| Metric | STVN | RGEN |
|---|---|---|
| Market Information | ||
| Market Cap | $6.00B | $7.02B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 295,683 | 697,970 |
| 90 Day Avg. Volume | 365,188 | 934,717 |
| Last Close | $21.99 | $121.26 |
| 52 Week Range | $17.12 - $28.00 | $102.97 - $182.52 |
| % from 52W High | -21.46% | -33.56% |
| All-Time High | $36.30 (Aug 07, 2023) | $327.32 (Sep 20, 2021) |
| % from All-Time High | -39.42% | -62.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.15% |
| Quarterly Earnings Growth | 0.44% | 1.60% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | -0.02% |
| Operating Margin (TTM) | 0.15% | 0.05% |
| Return on Equity (TTM) | 0.10% | -0.01% |
| Debt to Equity (MRQ) | 29.80 | 33.28 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.12 | $36.65 |
| Cash per Share (MRQ) | $0.38 | $12.60 |
| Operating Cash Flow (TTM) | $242.13M | $132.11M |
| Levered Free Cash Flow (TTM) | $-83,845,395 | $155.35M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Stevanato vs Repligen
| Metric | STVN | RGEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 38.58 | 511.11 |
| Forward P/E | 36.65 | 70.11 |
| PEG Ratio | 1.03 | 3.19 |
| Price to Sales (TTM) | 5.24 | 10.42 |
| Price to Book (MRQ) | 4.29 | 3.40 |
| Market Capitalization | ||
| Market Capitalization | $6.00B | $7.02B |
| Enterprise Value | $7.60B | $7.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.67 | 10.38 |
| Enterprise to EBITDA | 25.44 | 55.34 |
| Risk & Other Metrics | ||
| Beta | 0.55 | 1.05 |
| Book Value per Share (MRQ) | $5.12 | $36.65 |
Financial Statements Comparison: Stevanato vs Repligen
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | STVN | RGEN |
|---|---|---|
| Revenue/Sales | $328.07M | $182.37M |
| Cost of Goods Sold | $236.00M | $91.22M |
| Gross Profit | $92.07M | $91.14M |
| Research & Development | $7.08M | $13.96M |
| Operating Income (EBIT) | $48.46M | $5.96M |
| EBITDA | $73.69M | $33.81M |
| Pre-Tax Income | $45.82M | $18.22M |
| Income Tax | $11.02M | $3.35M |
| Net Income (Profit) | $34.80M | $14.87M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | STVN | RGEN |
|---|---|---|
| Cash & Equivalents | $110.32M | $697.23M |
| Total Current Assets | $1.01B | $1.03B |
| Total Current Liabilities | $564.21M | $152.00M |
| Long-Term Debt | $400.21M | $668.54M |
| Total Shareholders Equity | $1.64B | $1.99B |
| Retained Earnings | N/A | $413.18M |
| Property, Plant & Equipment | $131.42M | $265.24M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | STVN | RGEN |
|---|---|---|
| Operating Cash Flow | $56.70M | $14.16M |
| Capital Expenditures | $-67.08M | $-3.52M |
| Free Cash Flow | $-17.99M | $10.58M |
| Debt Repayment | $-33.73M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | STVN | RGEN |
|---|---|---|
| Shares Short | 2.03M | 3.64M |
| Short Ratio | 6.60 | 3.98 |
| Short % of Float | 0.04% | 0.09% |
| Average Daily Volume (10 Day) | 295,683 | 697,970 |
| Average Daily Volume (90 Day) | 365,188 | 934,717 |
| Shares Outstanding | 319.71M | 56.09M |
| Float Shares | 48.89M | 52.66M |
| % Held by Insiders | 0.02% | 0.06% |
| % Held by Institutions | 1.13% | 1.05% |
Dividend Analysis & Yield Comparison: Stevanato vs Repligen
| Metric | STVN | RGEN |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.04 | N/A |
| 3-Year Avg Dividend Yield | 0.26% | N/A |
| 3-Year Total Dividends | $0.12 | N/A |
| Ex-Dividend Date | Jun 04, 2024 | N/A |